Vice President Head Medical Anti Infective positions focus on delivering results in their domain. This page aggregates open Vice President Head Medical Anti Infective roles and what employers typically expect.
Azurity Pharmaceuticals is a privately held, specialty pharmaceutical company that focuses on innovative products that meet the needs of underserved patients. As an industry leader in providing unique, accessible, and high-quality medications, Azurity leverages its integrated capabilities and vast partner network to continually expand its broad commercial product portfolio and robust late-stage pipeline. The company’s patient-centric products span the cardiovascular, neurology, endocrinology, gastro-intestinal, institutional, and orphan markets, and have benefited millions of patients. For more information, visit [www.azurity.com](http://www.azurity.com/). Azurity Pharmaceuticals is proud to be an inclusive workplace and an Equal Opportunity Employer. Azurity's success is attributable to our incredibly talented, dedicated team that focuses on benefiting the lives of patients by bringing the best science and commitment to quality into everything that we do. We seek highly motivated individuals with the dedication, integrity, and creative spirit needed to thrive in our organization. **Job Title: Vice President, Head of Medical –** **Anti-Infective, Respiratory, Gastrointestinal & Other Therapeutic Areas (ARGO)** **Department:** CMO Office **Reports To:** Chief Medical Officer **Location:** Raleigh (United States) **Level:** Executive / VP **Position Summary** **Azurity Pharmaceuticals** is seeking a **Vice President, Head of Medical –** **Anti-Infective, Respiratory, Gastrointestinal & Other Therapeutic Areas (ARGO)** to provide senior medical and scientific leadership across Azurity’s portfolio in **global markets**. This role is accountable for defining and executing integrated medical strategies that support scientific differentiation, clinical value, and lifecycle advancement across Anti-Infective, Respiratory, Gastrointestinal, and additional therapeutic areas within the portfolio. Reporting directly to the **Chief Medical Officer**, this executive will oversee a team of **Medical Leads** aligned to these therapeutic areas. The role will partner closely with **Commercial Brand Executives** and **Franchise Portfolio Management** to ensure medical strategy and ipunt is embedded into brand planning, portfolio prioritization, and long-range value creation—while upholding the highest standards of scientific integrity, compliance, and patient centricity. **Key Responsibilities** **Medical Strategy Leadership** **Anti-Infective, Respiratory, Gastrointestinal & Other Therapeutic Areas (ARGO)** - Own and drive **end-to-end medical strategy** across cardiology, endocrinology, and other assigned therapeutic areas in **global markets**, ensuring alignment with Azurity’s enterprise medical vision and business objectives. - Define portfolio-level medical strategic imperatives, including **unmet need, disease burden, scientific differentiation, evidence requirements, and lifecycle opportunities**. - Ensure consistent medical positioning and strategic clarity across brands, indications, and treatment settings globally. **Leadership of Medical Leads** - Lead, mentor, and develop a team of **Medical Leads** supporting Anti-Infective, Respiratory, Gastrointestinal and other therapeutic areas (ARGO) - Establish clear frameworks, standards, and expectations for **brand-level medical strategy development, execution, and measurement**. - Ensure Medical Strategy function is highly collaborative, credible scientific expert ands trusted strategic partner by Commercial Brand Executives and Franchise Portfolio leaders. **Integrated Brand & Lifecycle Planning** - Partner closely with **Commercial Brand Executives** to align ARGO portfolio’s medical strategy with overall brand strategy, launch planning, and execution—while maintaining appropriate medical function’s compliance. - Collaborate with **Franchise Portfolio Management** to inform **portfolio prioritization, indication sequencing and timing, formulation strategies, and long-range lifecycle pla…